Log In
BCIQ
Print this Print this
 

dulaglutide (GLP-1Fc, Trulicity) (LY2189265)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionLong-acting glucagon-like peptide-1 (GLP-1) receptor agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerSumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/09/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today